January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with ...

It’s been spruiked as everything from cutting-edge science to an unethical wasteland masquerading as healthcare.

Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with ...

T.J. Atchinson is first person with a spinal cord injury to undergo procedure. June 2, 2011 -- Dr. Donald Leslie, medical director at the Shepherd Center in Atlanta, has high hopes. "We want to cure ...

Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at the University of California, Irvine, has received an $11,999,933 grant from the ...

These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...